Holen Sie sich die Stockscreener-App
12.24
4.97%
0.58
Schlusskurs vom Vortag:
$11.66
Offen:
$12
24-Stunden-Volumen:
5,575
Relative Volume:
0.20
Marktkapitalisierung:
$108.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-61.23M
KGV:
-0.9054
EPS:
-13.5194
Netto-Cashflow:
$22.49M
1W Leistung:
-13.68%
1M Leistung:
+41.83%
6M Leistung:
-27.06%
1J Leistung:
-5.92%
1-Tages-Spanne:
$11.64
$13.29
1-Wochen-Bereich:
$11.64
$14.79
52-Wochen-Spanne:
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie ASMB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
12.24 | 108.30M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register
Assembly Biosciences Reports Q1 2025 Earnings - TipRanks
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast - GuruFocus
Assembly Biosciences Updates on Clinical Progress and Financials, Anticipates Key Data in 2025 - Nasdaq
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences (ASMB) Highlights Promising Preclinical Data at EASL Congress | ASMB Stock News - GuruFocus
New Preclinical Data for Assembly Biosciences' Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025 - The Manila Times
Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA - Yahoo Finance
Raymond James Financial Inc. Invests $973,000 in Invesco 0-5 Yr US TIPS ETF (BATS:PBTP) - The AM Reporter
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock? - NewsBreak: Local News & Alerts
Learn to Evaluate (ASMB) using the Charts - news.stocktradersdaily.com
JPMorgan Chase & Co. Acquires 7,918 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Assembly Biosciences Insiders Added US$679.4k Of Stock To Their Holdings - simplywall.st
Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Renaissance Technologies LLC Boosts Stock Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Long Term Trading Analysis for (ASMB) - news.stocktradersdaily.com
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
ASMB stock touches 52-week low at $8.21 amid market challenges By Investing.com - Investing.com South Africa
Mastercard Is Taking On the World and Winning - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st
(ASMB) Investment Report - news.stocktradersdaily.com
Consumer Internet Stocks Q4 Teardown: Remitly (NASDAQ:RELY) Vs The Rest - The Globe and Mail
Assembly Biosciences CEO sells shares worth $3,496 By Investing.com - Investing.com Canada
Assembly Biosciences officer sells $1,772 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $3,496 - Investing.com
Assembly Biosciences officer sells shares for $1,940 - Investing.com India
Assembly Biosciences officer sells $1,772 in stock - Investing.com India
Five9 (FIVN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
ASMB stock touches 52-week low at $10.1 amid market challenges - Investing.com
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Research Analysts Offer Predictions for ASMB Q1 Earnings - Defense World
Guggenheim Initiates Coverage of Assembly Biosciences (ASMB) with Buy Recommendation - MSN
Research Analysts Issue Forecasts for ASMB FY2029 Earnings - Defense World
Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim - Defense World
Assembly Biosciences Reports 2024 Financial Results and Progress - TipRanks
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Guggenheim Initiates Assembly Biosciences at Buy With $31 Price Target - MarketScreener
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Assembly Biosciences Inc-Aktie (ASMB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bjorkquist Jeanette M | Principal Accounting Officer |
Mar 31 '25 |
Sale |
9.85 |
180 |
1,773 |
4,617 |
| Okazaki Jason A | CEO and President |
Mar 31 '25 |
Sale |
9.85 |
355 |
3,496 |
14,757 |
| White Nicole S | Chief Manufacturing Officer |
Mar 31 '25 |
Sale |
9.85 |
197 |
1,940 |
11,674 |
| Houghton Michael | Director |
Dec 30 '24 |
Buy |
15.61 |
3,202 |
49,998 |
3,202 |
| GILEAD SCIENCES, INC. | 10% Owner |
Dec 19 '24 |
Buy |
21.37 |
940,499 |
20,098,464 |
2,209,471 |
| Schornstein Alexander | 10% Owner |
Nov 22 '24 |
Buy |
14.87 |
17,024 |
253,104 |
720,137 |
| Schornstein Alexander | 10% Owner |
Nov 25 '24 |
Buy |
14.91 |
7,976 |
118,890 |
728,113 |
| White Nicole S | Chief Manufacturing Officer |
Nov 18 '24 |
Sale |
16.29 |
40 |
652 |
11,871 |
| Schornstein Alexander | 10% Owner |
Oct 08 '24 |
Buy |
14.58 |
10,000 |
145,800 |
703,113 |
| White Nicole S | Chief Manufacturing Officer |
Oct 03 '24 |
Sale |
14.81 |
157 |
2,325 |
11,911 |
0.84%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):